Press release
Uveal Melanoma Pipeline Analysis (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals, Competitive Landscape | Novartis, AstraZeneca, Roche, IDEAYA, Merck, GSK, Janssen, Foghorn, TriSalus, Array BioPharma, Ono Pharma
"Uveal Melanoma Pipeline Insight, 2023" report by DelveInsight provides a comprehensive analysis of the ongoing clinical development activities and growth prospects across the Uveal Melanoma Therapeutics Market.
The report provides a detailed description of the Uveal Melanoma drugs, including the mechanism of action, type, stage, route of administration, molecule type, clinical studies, inactive pipeline products, and NDA approvals (if any). The report also covers commercial and clinical activities of the pipeline products from the pre-clinical developmental phase to the marketed stage. Additionally, it presents the ongoing developments in the therapeutics segment, including collaborations, licensing, mergers & acquisitions (M&A), funding, designations, and other product-related details.
Get a Detailed Overview of the Uveal Melanoma Clinical Trial Activities and Regulatory Developments in the domain @
https://www.delveinsight.com/report-store/uveal-melanoma-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Uveal Melanoma Pipeline Analysis
The report provides insights into:
• The report provides detailed insights into the key companies that are developing Uveal Melanoma therapies.
• The report also evaluates different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Uveal Melanoma treatment.
• It analyzes the key companies involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• It navigates the emerging Uveal Melanoma drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement, and financing details for future advancement in the Uveal Melanoma treatment market.
Learn More about the Clinical and Commercial Development Activities in the Uveal Melanoma Therapeutics Domain @
https://www.delveinsight.com/report-store/uveal-melanoma-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Uveal Melanoma Therapeutics Analysis
There are approx. 25+ key companies developing therapies for Intraocular (Uveal) melanoma. Currently, BioMed Valley Discoveries, Inc, is leading the therapeutics market with its Intraocular (Uveal) melanoma drug candidates in the most advanced stage of clinical development.
Uveal Melanoma Companies in the Therapeutics Market Include:
• Novartis Pharmaceuticals
• Foghorn Therapeutics
• TriSalus Life Sciences, Inc.
• Bristol Myers Squibb
• Array BioPharma
• Ono Pharmaceutical
• AstraZeneca
• Roche
• IDEAYA Biosciences
• Merck & Co
• GlaxoSmithKline
• Janssen
And Many Others
Emerging and Marketed Uveal Melanoma Therapies Covered in the Report Include:
• BVD-523: BioMed Valley Discoveries, Inc
• AU-011: Aura Biosciences, Inc
• PAC-1: Vanquish Oncology
And Many More
Get an in-depth Assessment of the Emerging Therapies and Uveal Melanoma Companies Actively Working in the Market @
https://www.delveinsight.com/sample-request/uveal-melanoma-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
The Report Covers the Emerging Uveal Melanoma Therapies Under Different Phases of Clinical Development Like -
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued and inactive candidates
Route of Administration
Intraocular(Uveal) melanoma pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as
• Oral
• Subcutaneous
• Intravenous
• Intramuscular
Molecule Type
Products have been categorized under various Molecule types such as
• Bispecific Antibody
• Peptides
• Small molecule
• Gene therapy
Request for Sample PDF to Understand More About the Uveal Melanoma Treatment Outlook and Future Perspectives @
https://www.delveinsight.com/sample-request/uveal-melanoma-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Table of Content
1. Report Introduction
2. Executive Summary
3. Uveal Melanoma Current Treatment Patterns
4. Uveal Melanoma - DelveInsight's Analytical Perspective
5. Therapeutic Assessment
6. Uveal Melanoma Late-Stage Products (Phase-III)
7. Uveal Melanoma Mid-Stage Products (Phase-II)
8. Early Stage Products (Phase-I)
9. Pre-clinical Products and Discovery Stage Products
10. Inactive Products
11. Dormant Products
12. Uveal Melanoma Discontinued Products
13. Uveal Melanoma Product Profiles
14. Uveal Melanoma Companies
15. Uveal Melanoma Drugs
16. Dormant and Discontinued Products
17. Uveal Melanoma Unmet Needs
18. Uveal Melanoma Future Perspectives
19. Uveal Melanoma Analyst Review
20. Appendix
21. Report Methodology
Get Detailed Insights About the Reports Offerings @
https://www.delveinsight.com/sample-request/uveal-melanoma-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
------------------------------------------------------------------------------------------------------------------------------
Discover DelveInsight's Comprehensive Market Research and Consulting Services:
https://www.delveinsight.com/market-research
Elevate your industry insights with our comprehensive medical devices market assessment reports. Visit to gain a strategic edge through expert analysis and in-depth coverage of the latest trends, innovations, and market dynamics, at:
https://www.delveinsight.com/medical-devices
Empowering Cancer Care: DelveInsight's oncology consulting services offer personalized guidance and cutting-edge expertise to navigate the ongoing clinical, commercial, and regulatory developments, visit for more details:
https://www.delveinsight.com/oncology
Other Trending Healthcare Reports by DelveInsight
Metrorrhagia Market
https://www.delveinsight.com/report-store/metrorrhagia-market
Dysfunctional Uterine Bleeding Market
https://www.delveinsight.com/report-store/dysfunctional-uterine-bleeding-market
Status Epilepticus Market
https://www.delveinsight.com/report-store/status-epilepticus-market
Brain Hemorrhage Market
https://www.delveinsight.com/report-store/brain-hemorrhage-market
Congenital Adrenal Hyperplasia Market
https://www.delveinsight.com/report-store/congenital-adrenal-hyperplasia-market
Ductal Carcinoma in Situ Market
https://www.delveinsight.com/report-store/ductal-carcinoma-in-situ-market
Electroencephelographs (EEG) Pipeline Insight
https://www.delveinsight.com/report-store/electroencephelographs-eeg-pipeline-insight-and-competitive-landscape
Spinal Decompression/Traction Devices Market
https://www.delveinsight.com/report-store/spinal-decompression-traction-devices-market
Bronchopulmonary Dysplasia Market
https://www.delveinsight.com/report-store/bronchopulmonary-dysplasia-market
Drug Hypersensitivity Market
https://www.delveinsight.com/report-store/drug-hypersensitivity-market
Familial Chylomicronemia Syndrome (FCS) Market
https://www.delveinsight.com/report-store/familial-chylomicronemia-syndrome-market
Implantable Infusion Pumps Market
https://www.delveinsight.com/report-store/implantable-infusion-pumps-market
Postmyocardial Infarction Syndrome Market
https://www.delveinsight.com/report-store/postmyocardial-infarction-syndrome-market
Surgery and Radiation Therapy in Brain Cancer Market
https://www.delveinsight.com/report-store/surgery-and-radiation-therapy-in-brain-cancer-market
Acute ischemic stroke (AIS) Market
https://www.delveinsight.com/report-store/acute-ischemic-stroke-ais-market
Acute On Chronic Liver Failure (ACLF) Market
https://www.delveinsight.com/report-store/acute-on-chronic-liver-failure-aclf-market
Biliary Tract Cancers (BTCs) Market
https://www.delveinsight.com/report-store/biliary-tract-cancers-btcs-market
Gene Therapy for Ocular Rare Disease Market
https://www.delveinsight.com/report-store/gene-therapy-for-ocular-rare-disease-market
Hemophagocytic Lymphohistiocytosis Market
https://www.delveinsight.com/report-store/hemophagocytic-lymphohistiocytosis-market
Staphylococcus Aureus Infection Market
https://www.delveinsight.com/report-store/staphylococcus-aureus-infection-market
Treatment-Resistant Hypertension Market
https://www.delveinsight.com/report-store/treatment-resistant-hypertension-market
Urticaria Or Hives Market
https://www.delveinsight.com/report-store/urticaria-or-hives-market
Acute Heart failure Market
https://www.delveinsight.com/report-store/acute-heart-failure-ahf-market
Bowen's Disease Market
https://www.delveinsight.com/report-store/bowens-disease-market
Contrast-Induced Nephropathy Market
https://www.delveinsight.com/report-store/contrast-induced-nephropathy-market
Delirium Market
https://www.delveinsight.com/report-store/delirium-market
Dry AMD MarketEGFR Inhibitors-Induced Skin Disorders Market
https://www.delveinsight.com/report-store/egfr-inhibitors-induced-skin-disorders-market
Excessive Daytime Sleepiness (EDS) Market
https://www.delveinsight.com/report-store/excessive-daytime-sleepiness-eds-market
Gene and Cell Therapies Targeting CNS Disorders Market
https://www.delveinsight.com/report-store/gene-and-cell-therapies-targeting-cns-disorders-market
Glioma Market
https://www.delveinsight.com/report-store/glioma-market
Graves Ophthalmopathy Market
https://www.delveinsight.com/report-store/graves-ophthalmopathy-market
H3N2 Infection Market
https://www.delveinsight.com/report-store/h3n2-infection-market
Nontuberculous Mycobacterial (NTM) Infections Market
https://www.delveinsight.com/report-store/nontuberculous-mycobacterial-ntm-infections-market
Pars Plantis Market
https://www.delveinsight.com/report-store/pars-plantis-market
Pneumothorax Treatment Devices Market
https://www.delveinsight.com/report-store/pneumothorax-treatment-devices-market
Portal Hypertension Market
https://www.delveinsight.com/report-store/portal-hypertension-market
Decompensated Cirrhosis Market
https://www.delveinsight.com/report-store/decompensated-cirrhosis-market
Follicular Lymphoma Market
https://www.delveinsight.com/report-store/follicular-lymphoma-market-insights
Osteochondromas Market
https://www.delveinsight.com/report-store/osteochondromas-market
Hidradenitis Suppurativa Market
https://www.delveinsight.com/report-store/hidradenitis-suppurativa-market
IgG4-Related Disease Market
https://www.delveinsight.com/report-store/igg4-related-disease-market
Lichen Planus Market
https://www.delveinsight.com/report-store/lichen-planus-market
Retinal Vein Occlusion Market
https://www.delveinsight.com/report-store/retinal-vein-occlusion-market
Meniere's Disease Market
https://www.delveinsight.com/report-store/menieres-disease-md-market
Cytokine Release Syndrome Market
https://www.delveinsight.com/report-store/cytokine-release-syndrome-market
Angelman Syndrome Market
https://www.delveinsight.com/report-store/angelman-syndrome-market-forecast
Eosinophilic Gastroenteritis (EGE) Market
https://www.delveinsight.com/report-store/eosinophilic-gastroenteritis-ege-market
Hereditary Transthyretin Amyloidosis (hATTR) Market
https://www.delveinsight.com/report-store/hereditary-transthyretin-amyloidosis-competitive-landscape-and-market
Implantable Infusion Pumps Market
https://www.delveinsight.com/report-store/implantable-infusion-pumps-market
Post-Operative Cataract Surgery Inflammation Market
https://www.delveinsight.com/report-store/post-operative-cataract-surgery-inflammation-market
Antibody-mediated Rejection Market
https://www.delveinsight.com/report-store/antibody-mediated-rejection-market
Contact Info:
Shruti Thakur
Manager - Marketing & International Branding
Email: info@delveinsight.com
428, D21 Corporate Park, Sector-21, Dwarka, New Delhi-110077, India
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Uveal Melanoma Pipeline Analysis (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals, Competitive Landscape | Novartis, AstraZeneca, Roche, IDEAYA, Merck, GSK, Janssen, Foghorn, TriSalus, Array BioPharma, Ono Pharma here
News-ID: 3263245 • Views: …
More Releases from DelveInsight Business Research LLP
Genital Warts Pipeline Insights Report 2025 | DelveInsight
DelveInsight's, "Genital Warts Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Genital Warts pipeline landscape. It covers the Genital Warts pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight and stay ahead…
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
DelveInsight's "Traumatic Brain Injury Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Tthe raumatic Brain Injury pipeline landscape. It covers the Traumatic Brain Injury pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Traumatic Brain Injury pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore…
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
DelveInsight's, "Bone Metastases Pipeline Insight, 2025," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Bone Metastases pipeline landscape. It covers the Bone Metastasis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bone Metastasis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight…
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsi …
DelveInsight's "Acquired Immunodeficiency Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Acquired Immunodeficiency Syndrome, historical and forecasted epidemiology as well as the Acquired Immunodeficiency Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
To Know in detail about the Acquired Immunodeficiency Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Acquired Immunodeficiency Syndrome Market…
More Releases for Uveal
Metastatic Uveal Melanoma Therapeutics Market: An In-Depth Analysis
The Metastatic Uveal Melanoma Therapeutics market was valued at USD 1.23 billion in 2023 and is projected to reach approximately USD 3.00 billion by 2033, growing at an estimated CAGR of around 8.9% from 2024 to 2033.
Metastatic Uveal Melanoma Therapeutics Market Overview
The Metastatic Uveal Melanoma Therapeutics market is evolving rapidly with the emergence of novel targeted and immunotherapeutic treatments addressing this rare and aggressive cancer. Increasing research into tumor-specific pathways…
Metastatic Uveal Melanoma Therapeutics Market Future Prediction Report By 2030
𝐆𝐥𝐨𝐛𝐚𝐥 𝐦𝐞𝐭𝐚𝐬𝐭𝐚𝐭𝐢𝐜 𝐮𝐯𝐞𝐚𝐥 𝐦𝐞𝐥𝐚𝐧𝐨𝐦𝐚 𝐭𝐡𝐞𝐫𝐚𝐩𝐞𝐮𝐭𝐢𝐜𝐬 𝐦𝐚𝐫𝐤𝐞𝐭 𝐰𝐚𝐬 𝐯𝐚𝐥𝐮𝐞𝐝 𝐚𝐭 𝐚𝐩𝐩𝐫𝐨𝐱𝐢𝐦𝐚𝐭𝐞𝐥𝐲 𝐔𝐒𝐃 𝟏.𝟐𝟑 𝐛𝐢𝐥𝐥𝐢𝐨𝐧. 𝐈𝐭 𝐢𝐬 𝐩𝐫𝐨𝐣𝐞𝐜𝐭𝐞𝐝 𝐭𝐨 𝐫𝐞𝐚𝐜𝐡 𝐚𝐫𝐨𝐮𝐧𝐝 𝐔𝐒𝐃 𝟐.𝟑𝟑 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 𝟐𝟎𝟑𝟎, 𝐞𝐱𝐡𝐢𝐛𝐢𝐭𝐢𝐧𝐠 𝐚 𝐜𝐨𝐦𝐩𝐨𝐮𝐧𝐝 𝐚𝐧𝐧𝐮𝐚𝐥 𝐠𝐫𝐨𝐰𝐭𝐡 𝐫𝐚𝐭𝐞 (𝐂𝐀𝐆𝐑) 𝐨𝐟 𝟖.𝟓𝟗% 𝐝𝐮𝐫𝐢𝐧𝐠 𝐭𝐡𝐞 𝐟𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝐩𝐞𝐫𝐢𝐨𝐝 𝐟𝐫𝐨𝐦 𝟐𝟎𝟐𝟒 𝐭𝐨 𝟐𝟎𝟑𝟎.
𝐌𝐞𝐭𝐚𝐬𝐭𝐚𝐭𝐢𝐜 𝐔𝐯𝐞𝐚𝐥 𝐌𝐞𝐥𝐚𝐧𝐨𝐦𝐚 𝐓𝐡𝐞𝐫𝐚𝐩𝐞𝐮𝐭𝐢𝐜𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐎𝐯𝐞𝐫𝐯𝐢𝐞𝐰
The metastatic uveal melanoma therapeutics market is experiencing significant growth, driven by the increasing incidence of uveal melanoma and advancements in treatment options. Uveal…
Global Uveal Melanoma Treatment Market Will Generate Record Revenue by 2028
This Uveal Melanoma Treatment market report is the product of thorough market study and comments on important factors that influence financial decision. Here, helpful insights on customer demands are provided in order to launch the best product or service on the market. COVID-19's detrimental effects on the world economy system are also captured in this way. As a result of the pandemic, some businesses experienced considerable financial losses. Several businesses…
Uveal Melanoma Therapeutics- Clinical Trials & Results | HARMONIC PHARMA, Immuno …
Uveal melanoma is the most common primary malignant tumour of intraocular malignancy, arises from melanocytes in the iris, and ciliary body.
Download the sample report @ https://www.pharmaproff.com/request-sample/1121
The most common symptoms of uveal carcinoma include blurred vision, photopsia, visual field loss, visible tumour, pain, and metamorphopsia. The management of uveal melanoma can be divided into globe-preserving therapy or enucleation. Globe-preserving therapies can broadly classified into radiation, surgical, and laser therapy.
Get…
Uveal Melanoma Global Market Research Report 2025
Uveal Melanoma Report by Material, Application, and Geography � Global Forecast to 2022 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China).
Access more details about this report at: https://www.research2reports.com/report-medical-devices/uveal-melanoma-market/80986
The report firstly introduced the Uveal Melanoma basics: definitions, classifications, applications and…
Uveal Melanoma Market By Analysis of Major Industry Segments 2024
Global Uveal Melanom Market: Overview
Uvea is present posterior to sclera and the cornea and has three parts namely, iris, ciliary body and choroid. Uveal melanoma is referred as the cancer of the parts of eye including the iris choroid and ciliray body. It is the condition in which the tumors arise from the melanocytes residing within the uva responsible for the color of the eye. Though is a rare…
